Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy

Somayyeh Ghareghomi ¹ , Vahideh Atabaki ² , Naseh Abdollahzadeh ³, Shahin Ahmadian ¹ * , Salar Hafez Ghoran ^4,5 *

Cited by CrossRef: 3

1- Liu Y, Ding W, Wang J, Ao X, Xue J. Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications. Front Oncol. 2023;13 [Crossref]

2- Hussain Y, Khan H, Alam W, Aschner M, Aschner A, Alsharif K, Saso L, Curcio M. Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy. Oxidative Medicine and Cellular Longevity. 2022;2022:1 [Crossref]

3- Iranpanah A, Majnooni M, Biganeh H, Amirian R, Rastegari‐Pouyani M, Filosa R, Cheang W, Fakhri S, Khan H. Exploiting new strategies in combating head and neck carcinoma: A comprehensive review on phytochemical approaches passing through PI3K/Akt/mTOR signaling pathway. Phytotherapy Research. 2024;38(7):3736 [Crossref]